On Friday, Analog Devices, Inc. (NASDAQ:ADI)’s shares inclined 1.37% to $55.69.
Analog Devices, Inc. (ADI) declared it is the primary sponsor and founding member of “Solve,” a multi-faceted program organized by the Massachusetts Institute of Technology (MIT) that convenes thought leaders, researchers, students, and change agents to identify and implement technology-centered solutions to the most difficult challenges of our times. Solve is part of HUBweek, a week-long city-wide festival taking place October 3-10, 2015, that will celebrate ideas and innovation in the Boston area. Solve kicks off with an inaugural event planned for October 5-8, 2015, at MIT. Solve is an ongoing initiative with participants reconvening regularly to share insights and move toward finding solutions.
Analog Devices, Inc. engages in the design, manufacture, and marketing of analog, mixed-signal, and digital signal processing integrated circuits (ICs) for use in industrial, automotive, consumer, and communication markets worldwide. It offers signal processing products that convert, condition, and process real-world phenomena, such as temperature, pressure, sound, light, speed, and motion into electrical signals.
Glu Mobile Inc. (NASDAQ:GLUU)’s shares gained 0.48% to $4.17.
Glu Mobile Inc. (GLUU), a leading global developer and publisher of free-to-play games for smartphone and tablet devices, declared the availability of ‘James Bond: World of Espionage’ on the App Store and Google Play.
Developed in partnership with MGM Interactive Inc. and Danjaq LLC, ‘James Bond: World of Espionage’ immerses players in the Bond universe of strategy and intelligence. A multiplayer game – players must think plannedally and make tactical decisions to recruit, train and deploy agents around the globe. Extensive social features counting PvP, real-time chat, guilds, leaderboards, and events offer players an innovative way to compete against and play alongside others.
Featuring over 100 real-world actors and models as agents and villains, the game’s photo-realistic style illustrates a vivid and engaging portrait of the Bond universe. Sophisticated graphics and CGI-inspired user-interface offer a highly compelling mobile gaming experience.
Glu Mobile Inc. develops, publishes, and markets a portfolio of games for the smartphones and tablet devices users. The company offers free-to-play action, casual, racing, and sports genre mobile games.
At the end of Friday’s trade, Integrated Device Technology Inc (NASDAQ:IDTI)‘s shares surged 5.11% to $21.18.
Integrated Device Technology, Inc. (IDT®) (IDTI) introduced jitter attenuator and frequency synthesizer devices that deliver ultra-high performance meeting the phase noise requirements of the most stringent applications, counting JESD204B-compliant RF timing. The 8V19N407 and 8V19N408 support up to 3 GHz output frequencies, in addition to 82 femtoseconds of RMS phase noise, addressing the requirements of multi-carrier GSM radio transceivers in addition to 40 and 100 Gb Ethernet PHYs and other high-performance applications.
The 8V19N407 and 8V19N408 generate clock and SYSREF signals for JESD204B subclass 1-compliant ADC/DAC converters in wireless, industrial and radar applications. These devices output multiple high-performance synchronized clocks that are also ideal for high-speed Ethernet and cable TV head-end applications.
Integrated Device Technology, Inc. designs, develops, manufactures, and markets a range of semiconductor solutions for the communications, computing, and consumer industries worldwide.
Biogen Inc (NASDAQ:BIIB), ended its Friday’s trading session with 1.06% gain, and closed at $290.35.
Biogen (BIIB) will present new clinical data for its multiple sclerosis (MS) portfolio of therapies, counting the most-prescribed oral treatment, TECFIDERA® (dimethyl fumarate), at the 31st meeting of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) in Barcelona, Spain, 7-10 October 2015.1 TECFIDERA data will demonstrate its strong and sustained efficacy in relapsing-remitting multiple sclerosis (RRMS) among patients who were early in the course of their disease or newly diagnosed.
Previous studies have suggested that delaying MS treatment may put some patients at a higher risk of disease progression than those treated with an effective disease modifying therapy (DMT) early in their disease course. With a chronic condition like MS, initiating treatment early may assist slow disease activity.
Biogen Inc. discovers, develops, manufactures, and markets therapies for the treatment of neurological, autoimmune, and hematologic disorders in the United States and internationally.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should might occur.
